Thalidomide-NH-C4-NH-Boc is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of more complex molecules, particularly those targeting specific biological pathways. This compound is often employed in the design and creation of proteolysis-targeting chimeras (PROTACs), which are innovative therapeutic agents that degrade disease-causing proteins. Its structure allows for precise modifications, enabling researchers to optimize drug efficacy and selectivity. Additionally, it is used in the study of protein-protein interactions and the development of targeted therapies for conditions such as cancer and inflammatory diseases. Its Boc-protected amine group facilitates controlled reactions, making it a valuable tool in organic synthesis.